BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8547169)

  • 1. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension.
    Seckl JR; Benediktsson R; Lindsay RS; Brown RW
    J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):447-55. PubMed ID: 8547169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease.
    Seckl JR
    Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring.
    Welberg LA; Seckl JR; Holmes MC
    Eur J Neurosci; 2000 Mar; 12(3):1047-54. PubMed ID: 10762336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
    Edwards CR; Benediktsson R; Lindsay RS; Seckl JR
    Steroids; 1996 Apr; 61(4):263-9. PubMed ID: 8733012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone.
    Lindsay RS; Lindsay RM; Waddell BJ; Seckl JR
    Diabetologia; 1996 Nov; 39(11):1299-305. PubMed ID: 8932995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids.
    Yang K
    Rev Reprod; 1997 Sep; 2(3):129-32. PubMed ID: 9414475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal osteocalcin levels are related to placental 11 beta-hydroxysteroid dehydrogenase activity in humans.
    Benediktsson R; Brennand J; Tibi L; Calder AA; Seckl JR; Edwards CR
    Clin Endocrinol (Oxf); 1995 May; 42(5):551-5. PubMed ID: 7621576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of placental 11beta-hydroxysteroid dehydrogenase (11beta-HSD) inhibition on glucose metabolism and 11beta-HSD regulation in adult offspring of rats.
    Saegusa H; Nakagawa Y; Liu YJ; Ohzeki T
    Metabolism; 1999 Dec; 48(12):1584-8. PubMed ID: 10599992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis.
    Stewart PM; Rogerson FM; Mason JI
    J Clin Endocrinol Metab; 1995 Mar; 80(3):885-90. PubMed ID: 7883847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring.
    Lindsay RS; Lindsay RM; Edwards CR; Seckl JR
    Hypertension; 1996 Jun; 27(6):1200-4. PubMed ID: 8641724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD-II) activity in human placenta: its relationship to placental weight and birth weight and its possible role in hypertension.
    Hofmann M; Pollow K; Bahlmann F; Casper F; Steiner E; Brockerhoff P
    J Perinat Med; 2001; 29(1):23-30. PubMed ID: 11234613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR; Cleasby M; Nyirenda MJ
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform.
    Brown RW; Chapman KE; Edwards CR; Seckl JR
    Endocrinology; 1993 Jun; 132(6):2614-21. PubMed ID: 8504762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action.
    Waddell BJ; Benediktsson R; Brown RW; Seckl JR
    Endocrinology; 1998 Apr; 139(4):1517-23. PubMed ID: 9528929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
    Reynolds RM
    Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine placental 11 beta-hydroxysteroid dehydrogenase activity.
    Klemcke HG; Christenson RK
    Biol Reprod; 1996 Jul; 55(1):217-23. PubMed ID: 8793078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero.
    Bertram C; Trowern AR; Copin N; Jackson AA; Whorwood CB
    Endocrinology; 2001 Jul; 142(7):2841-53. PubMed ID: 11416003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental 11beta-hydroxysteroid dehydrogenase in Dahl and spontaneously hypertensive rats.
    Mazancova K; Miksik I; Kunes J; Pácha J
    Am J Hypertens; 2003 May; 16(5 Pt 1):401-6. PubMed ID: 12745203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action.
    Burton PJ; Waddell BJ
    Biol Reprod; 1999 Feb; 60(2):234-40. PubMed ID: 9915986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11 beta-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure.
    Burton PJ; Waddell BJ
    J Endocrinol; 1994 Dec; 143(3):505-13. PubMed ID: 7836896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.